Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance

Wild-type strains of Pseudomonas aeruginosa are more resistant to various beta-lactam antibiotics as well as other agents than most enteric bacteria. Although resistance to compounds of earlier generations is explained by the synergism between the outer membrane barrier and the inducible beta-lactamase, it was puzzling to see significant levels of resistance to compounds that do not act as inducers or are not hydrolyzed rapidly by the chromosomally encoded enzyme. This intrinsic-resistance phenotype becomes enhanced in those strains with the so-called intrinsic carbenicillin resistance. In the accompanying paper (X.-Z. Li, D. M. Livermore, and H. Nikaido, Antimicrob. Agents Chemother. 38:1732-1741, 1994), we showed that active efflux played a role in the resistance, to various non-beta-lactam agents, of P. aeruginosa strains in general and that the efflux was enhanced in intrinsically carbenicillin-resistant strains. We show in this paper that, in comparison with the drug-hypersusceptible mutant K799/61, less benzylpenicillin was accumulated in wild-type strains of P. aeruginosa and that the accumulation levels were even lower in intrinsically carbenicillin-resistant strains. Deenergization by the addition of a proton conductor increased the accumulation level to that expected for equilibration across the cytoplasmic membrane. In intrinsically carbenicillin-resistant isolates, there was no evidence that either nonspecific or specific permeation rates of beta-lactams across the outer membrane were lowered in comparison with those of the more susceptible isolates. Furthermore, these carbenicillin-resistant isolates were previously shown to have no alteration in the level or the inducibility of beta-lactamase and in the affinity of penicillin-binding proteins. These data together suggest the involvement of an active efflux mechanism also in the resistance to beta-lactams. Hydrophilic beta-lactams with more than one charged group did not cross the cytoplasmic membrane readily. Yet one such compound, ceftriaxone, appeared to be extruded from the cells of more-resistant strains, although with this compound effects of proton conductors could not be shown. We postulate that wild-type strains of P. aeruginosa pump out such hydrophilic beta-lactams either from the periplasm or from the outer leaflet of the lipid bilayer of the cytoplasmic membrane, in a manner analogous to that hypothesized for multidrug resistance protein of human cancer cells (M.M. Gottesman and I. Pastan, Annu. Rev. Biochem. 62:385-427, 1993).

[1]  D. Hooper,et al.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli , 1988, Antimicrobial Agents and Chemotherapy.

[2]  H. Nikaido,et al.  Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances. , 1976, Biochimica et biophysica acta.

[3]  H. Nikaido,et al.  Sensitivity of Escherichia coli to various β‐lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β‐lactamases: a quantitative predictive treatment , 1987, Molecular microbiology.

[4]  D. Livermore,et al.  Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to beta-lactam antibiotics , 1991, Antimicrobial Agents and Chemotherapy.

[5]  H. Nikaido Outer membrane barrier as a mechanism of antimicrobial resistance , 1989, Antimicrobial Agents and Chemotherapy.

[6]  R. Misra,et al.  Genetic identification of the pore domain of the OmpC porin of Escherichia coli K-12 , 1988, Journal of bacteriology.

[7]  D. Ecker,et al.  Escherichia coli iron enterobactin uptake monitored by Mössbauer spectroscopy , 1986, Journal of bacteriology.

[8]  H. Nikaido,et al.  Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa , 1989, Antimicrobial Agents and Chemotherapy.

[9]  A. Tsuji,et al.  Physicochemical Properties of β-Lactam Antibiotics: Oil-Water Distribution , 1977 .

[10]  D. Livermore Penicillin-binding proteins, porins and outer-membrane permeability of carbenicillin-resistant and -susceptible strains of Pseudomonas aeruginosa. , 1984, Journal of medical microbiology.

[11]  H. Goldfine Comparative aspects of bacterial lipids. , 1972, Advances in microbial physiology.

[12]  T. Beveridge,et al.  Ultrastructural examination of the lipopolysaccharides of Pseudomonas aeruginosa strains and their isogenic rough mutants by freeze-substitution , 1992, Journal of bacteriology.

[13]  H. Nikaido,et al.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells , 1983, Journal of bacteriology.

[14]  K. Bush,et al.  Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria , 1982, Antimicrobial Agents and Chemotherapy.

[15]  D. Livermore,et al.  Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin , 1994, Antimicrobial Agents and Chemotherapy.

[16]  F. Yoshimura,et al.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12 , 1985, Antimicrobial Agents and Chemotherapy.

[17]  J. Wootton,et al.  Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP‐binding transport super‐gene family , 1990, Molecular microbiology.

[18]  G. Rummel,et al.  Crystal structures explain functional properties of two E. coli porins , 1992, Nature.

[19]  W. Zimmermann Penetration of beta-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain , 1980, Antimicrobial Agents and Chemotherapy.

[20]  C. Bradbeer,et al.  Transport of vitamin B12 in Escherichia coli. Some observations on the roles of the gene products of BtuC and TonB. , 1980, The Journal of biological chemistry.

[21]  D. Livermore Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of beta-lactamase activity by PBP-5. , 1987, The Journal of antimicrobial chemotherapy.

[22]  J. Hearst,et al.  Molecular cloning and characterization of acrA and acrE genes of Escherichia coli , 1993, Journal of bacteriology.

[23]  V. Speth,et al.  Lateral mobility and surface density of lipopolysaccharide in the outer membrane of Salmonella typhimurium. , 1974, European journal of biochemistry.

[24]  W. Zimmermann,et al.  Function of the Outer Membrane of Escherichia coli as a Permeability Barrier to Beta-Lactam Antibiotics , 1977, Antimicrobial Agents and Chemotherapy.

[25]  S. Levy,et al.  Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.

[26]  D. Livermore Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa , 1992, Antimicrobial Agents and Chemotherapy.

[27]  K. Nikaido,et al.  Identification and characterization of porins in Pseudomonas aeruginosa. , 1991, The Journal of biological chemistry.

[28]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[29]  B. Spratt,et al.  Regulation of the permeability of the gonococcal cell envelope by the mtr system , 1994, Molecular microbiology.

[30]  D. Caron,et al.  Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant , 1982, Antimicrobial Agents and Chemotherapy.

[31]  H. Nikaido,et al.  Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins , 1983, Journal of bacteriology.

[32]  D. Livermore,et al.  β-Lactamase Lability and Inducer Power of Newer β-Lactam Antibiotics in Relation to Their Activity Against β-Lactamase-Inducibility Mutants of Pseudomonas aeruginosa , 1987 .

[33]  R. Hancock,et al.  Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells , 1991, Antimicrobial Agents and Chemotherapy.

[34]  A. Yamaguchi,et al.  Phospholipid bilayer permeability of beta-lactam antibiotics. , 1982, The Journal of antibiotics.

[35]  H. Nikaido,et al.  Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples , 1993, Antimicrobial Agents and Chemotherapy.

[36]  K. Poole,et al.  Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon , 1993, Journal of bacteriology.

[37]  A. M. George,et al.  Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline , 1983, Journal of bacteriology.

[38]  D. Hooper,et al.  Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation , 1989, Antimicrobial Agents and Chemotherapy.

[39]  N. Masuda,et al.  Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa , 1992, Antimicrobial Agents and Chemotherapy.

[40]  I. Pastan,et al.  Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. , 1985, Cancer research.

[41]  F. Yoshimura,et al.  Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes , 1982, Journal of bacteriology.